IP Library › Granted Patent US 8,859,020
Granted Patent B2
US 8,859,020 · App. 13/645,031 · Granted Oct 14, 2014

Treatment of alzheimer's with a curcuminoid mixture and essential oil of turmeric having 45% Ar-turmerone

Inventor: Benny Antony (Ankamaly, IN)
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,859,020
App. No.
13/645,031
Granted
Oct 14, 2014
Kind
B2
Abstract

Disclosure provides a formulation of curcuminoid with essential oil of turmeric to enhance the bioavailability of curcumin and to augment the biological activity of curcumin, wherein curcumin is the main constituent of curcuminoid and wherein Ar-turmerone is the main constituent of the essential oil of turmeric. An application of curcuminoid with essential oil of turmeric to enhance the bioavailability of curcumin for oral supplementation against a variety of diseases and method of doing the same is provided.

Claims (24)

1. A method of treating Alzheimer's disease comprising, administering to a subject in need thereof, an effective amount of a composition containing a curcuminoid mixture with an added essential oil of turmeric, wherein the weight ratio of the curcuminoid mixture to the added essential oil of turmeric ranges from about 1:3 to about 99:1; wherein the curcuminoid mixture consists of curcumin, demethoxycurcumin and bisdemethoxycurcumin and wherein the essential oil of turmeric comprises 45% ar-turmerone.

2. The method of claim 1 , wherein the composition is contained in a gelatin capsule.

3. The method of claim 2 , wherein the gelatin capsule comprises 500 mg of the composition.

4. The method of claim 3 , wherein the subject is administered three gelatin capsules twice daily.

5. The method of claim 3 , wherein the subject is administered one gelatin capsules twice daily.

6. The method of claim 1 , wherein the effective amount is 500 mg.

7. The method of claim 1 , wherein the composition contains 454.55 mg of the curcuminoid mixture.

8. The method of claim 1 , wherein the composition contains 45.45 mg of the essential oil of turmeric.

9. The method of claim 1 , wherein the composition contains 45.45 mg of the essential oil of turmeric and 454.55 mg of the curcuminoid mixture.

10. The method of any one of claims 6 , 7 , 8 and 9 , wherein said composition is contained in a gelatin capsule.

11. The method of claim 1 , wherein the composition is prepared by a method comprising:

suspending the curcuminoid mixture in water to form a suspension;

adding the essential oil of turmeric to the suspension to form a mixture;

homogenizing the mixture to obtain a slurry and drying the slurry under heat and vacuum to form a uniform blend.

12. The method of claim 1 , wherein said method increases Vitamin E levels in said subject.

13. The method of claim 1 , wherein said method increases serum level of amyloid beta in said subject.

14. The method of claim 1 , wherein said method lowers plasma isoprostane levels in said subject.

15. The method of claim 1 , wherein the weight ratio of the curcuminoid mixture to the essential oil of turmeric is 10:1.

16. The method of claim 1 , wherein the weight ratio of the curcuminoid mixture to the essential oil of turmeric is 12:1.

17. The method of claim 1 , wherein the composition contains about 461.5 mg of the curcuminoid mixture.

18. The method of claim 1 , wherein the composition contains about 38.45 mg of the essential oil of turmeric.

19. The method of claim 1 , wherein the composition contains about 461.5 mg of the curcuminoid mixture and about 38.5 mg of essential oil of turmeric.

20. The method of claim 1 , wherein the weight ratio of the curcuminoid mixture to the essential oil of turmeric is about 40:1 to about 95:5.

21. The method of claim 1 , wherein the effective amount is 3 grams.

Priority Claims (1)
IN 950CHE2010 · Apr 5, 2010 · national
Continuity (13)
Continuation In Part 13385717 · Mar 5, 2012
Division 12926985 · Dec 21, 2010
Division 12662740 · Apr 30, 2010
Division 11635599 · Dec 8, 2006
Continuation PCTIN2005000176 · May 30, 2005
Continuation 13645031
Continuation In Part PCTIN2011000232 · Apr 4, 2011
Continuation In Part 13506572 · Apr 30, 2012
Division 12926980 · Dec 21, 2010
Division 12073864 · Mar 11, 2008
Continuation In Part 11635599
Continuation PCTIN2005000176
Related Publication 20140099390A1 · Apr 10, 2014